about
Propagation of prions causing synucleinopathies in cultured cellsMultifaceted Role of Sialylation in Prion DiseasesThe Role of Amyloid-β Oligomers in Toxicity, Propagation, and ImmunotherapyInsights into Mechanisms of Chronic NeurodegenerationEvidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonismMeasurement of amyloid formation by turbidity assay-seeing through the cloudPrion DiseasesA brief history of prionsAnalysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease PrionsFrontotemporal Dementia.The Malignant Protein Puzzle.Types and Strains: Their Essential Role in Understanding Protein Aggregation in Neurodegenerative Diseases.Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion StrainsExpanding the prion disease repertoire.Early Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in MiceInactivation of Prions and Amyloid Seeds with Hypochlorous Acid.Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration.Two alternative pathways for generating transmissible prion disease de novo.Elucidating the structure of an infectious protein.Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.A Decentralized Approach to the Formulation of Hypotheses: A Hierarchical Structural Model for a Prion Self-Assembled SystemUnique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.Prions and Protein Assemblies that Convey Biological Information in Health and Disease.Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly.Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.Targeting α-synuclein: Therapeutic options.Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.Transfer of disrupted-in-schizophrenia 1 aggregates between neuronal-like cells occurs in tunnelling nanotubes and is promoted by dopamine.Prion-like propagation as a pathogenic principle in frontotemporal dementia.Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.Neurodegeneration: From cellular concepts to clinical applications.Developing Therapeutics for PrP Prion Diseases.The Gut Microbiota and Alzheimer's Disease.
P2860
Q26269822-33CD02EA-FCDA-4311-A0BB-A7BD623B04E5Q26739884-CF0122F4-B489-484D-A0AE-9F2933FD166FQ26747107-67EA2FAD-D562-4D8C-952D-036BB7111397Q26771732-5D07E1D0-AE3B-4CE4-8997-194528073472Q26782028-111192F0-BD7D-48E3-989F-3CF8AC4C0E14Q28080287-9D33323E-88FC-4EB1-9437-240A1BCC149AQ28080751-4BC86AD2-83A1-4DAE-9179-05D08C618AA9Q28085285-75191867-0D16-4A58-BB1B-8AAE4ADC86CEQ28831096-B871A366-B3F7-4B71-B17B-DF1263C48B05Q30234793-AA79DC79-F28F-4C53-B5F1-EC01639F4350Q33363509-1743A3CE-06CD-4F8C-88AB-131618DE4350Q33804420-B29592AB-0DEE-4371-8EBA-5F2A19A1E1F6Q35979953-D5CD1DE6-979C-42BA-8D9D-34166452DFFBQ36102969-1AF8BD75-E0F8-46FF-9121-FBF1F71DC7F5Q36143652-1745736F-44D7-4D2D-B20F-35F5140D15D1Q36148348-C4AB95D6-8830-4056-B127-47C74D3A47E5Q36202381-6F2EE7F2-D6E6-409F-8B8C-060086E4DC72Q36270558-1A3215CF-DB20-443B-89F7-38A41FCE3ED2Q36346000-160B6D36-C31C-419A-9671-E1581E5A04FEQ36480238-05D325C9-520A-4FA9-979A-1E3B4D805F6BQ36680395-66B64CF1-99AB-4D11-8722-DC5780E13A44Q37066447-AF4BD903-36C9-4B4C-8072-4CA07FB3EC68Q37134269-2BAE8218-E692-4162-99AA-C8DA0E0AD107Q37415258-20FD82E3-941A-4DCF-AA57-3F2C130D60C0Q38336025-4B49DEA5-5FD8-49A5-BE2D-61C116FD25D9Q38388660-D2A3350C-139B-402D-BA77-8EC14A3FAF8CQ38690632-09181235-C1BB-4007-A83F-995990B91659Q38754587-8BB7320F-067F-4281-B88D-9D5D43498937Q38807908-A3F8664E-57CF-4FA8-9A98-A9662B0E2111Q38836004-9B60C383-1EA5-4792-9D30-128C78BCC6C2Q38857573-485C9FE4-5EBB-42F4-BEA0-4C6EDF3B14B4Q38866202-2429082C-E637-4F0E-B1EF-7FA77CE6198BQ38919714-1FC866E3-A22E-48DA-A6B5-352EF60FC881Q38922025-E0D71F6A-F875-4735-AA80-67C04F6F7081Q38942540-059BD8D3-9F87-44DC-9045-3E8C4CB00AECQ38955990-727A7881-B8D6-4C80-9FA5-B88E9E349955Q38999345-ED842008-716F-479C-86E6-16B22BADF3B8Q39004490-67B5FD39-619F-4B81-BC83-F5F3CD3D2BEFQ39092621-948EA025-0A1F-40B6-AFE3-CE2191B6BD2EQ39217126-E1D68FBA-07DA-445B-A63F-92F6ED285D4E
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Neurodegenerative diseases: expanding the prion concept
@ast
Neurodegenerative diseases: expanding the prion concept
@en
Neurodegenerative diseases: expanding the prion concept
@nl
type
label
Neurodegenerative diseases: expanding the prion concept
@ast
Neurodegenerative diseases: expanding the prion concept
@en
Neurodegenerative diseases: expanding the prion concept
@nl
prefLabel
Neurodegenerative diseases: expanding the prion concept
@ast
Neurodegenerative diseases: expanding the prion concept
@en
Neurodegenerative diseases: expanding the prion concept
@nl
P2860
P3181
P1476
Neurodegenerative diseases: expanding the prion concept
@en
P2093
Lary C. Walker
P2860
P304
P3181
P356
10.1146/ANNUREV-NEURO-071714-033828
P407
P577
2015-07-08T00:00:00Z